Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologi... Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.15 | 7.02844066688 | 30.59 | 35.2 | 30.19 | 186686 | 32.57483358 | CS |
| 4 | 5.35 | 19.5326761592 | 27.39 | 35.2 | 27 | 136986 | 30.52606212 | CS |
| 12 | 3.28 | 11.1337406653 | 29.46 | 35.2 | 26.3112 | 194225 | 29.17752154 | CS |
| 26 | 11.76 | 56.0533841754 | 20.98 | 36.03 | 16.77 | 284791 | 26.15590124 | CS |
| 52 | 13.18 | 67.3824130879 | 19.56 | 36.03 | 14.385 | 350771 | 21.47257565 | CS |
| 156 | 15.84 | 93.7278106509 | 16.9 | 61.07 | 13.7 | 264116 | 24.98145591 | CS |
| 260 | 15.84 | 93.7278106509 | 16.9 | 61.07 | 13.7 | 264116 | 24.98145591 | CS |
TIMGZ
1年前
tw0122
1年前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。